SPP1 and metabolic dysfunction-associated steatotic liver disease: Accumulating research mentioned the key effect on the tumor transformation, especially the deficiency of SPP1 in mouse model, suggesting that the SPP1 knockdown can inhibit the transformation from MASLD to HCC [19].